RESEARCH ARTICLE


Smoking and Predictors of Pneumonia Among HIV-Infected Patients Receiving Care in the HAART Era



David M Murdoch*, 1, 2, Sonia Napravnik3, Joseph J Eron Jr3, Annelies Van Rie2
1 Division of Pulmonary & Critical Care Medicine, Duke University Medical Center, Durham, North Carolina
2 Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
3 Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 486
Abstract HTML Views: 295
PDF Downloads: 130
Total Views/Downloads: 911
Unique Statistics:

Full-Text HTML Views: 175
Abstract HTML Views: 157
PDF Downloads: 94
Total Views/Downloads: 426



Bentham Science Publishers Ltd.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/) which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.

* Address correspondence to this author at the Division of Pulmonary & Critical Care Medicine, Duke University Medical Center, Durham, North Carolina, USA; E-mail: david.murdoch@duke.edu


Abstract

Background: Smoking tobacco is disproportionably common among HIV-infected patients in the highly active antiretroviral therapy (HAART) era. Methods: An observational cohort study of 300 HIV-positive patients receiving care between 1996 and 2005 examined the effect of smoking on pneumonia risk. Multivariable analyses assessed the association between smoking and pneumonia risk and identified independent predictors of pneumonia during the HAART era. Results: Current smoking was common (67%). Eighty-two patients (27%) experienced 119 pneumonia episodes during 2151 patient-years of follow-up, with 7.2 episodes/100 person-years among smokers and 2.9 episodes/100 person-years among non-smokers (unadjusted incidence rate ratio (IRR): 2.50 (95% CI: 1.58, 4.09). Adjustment for age and HIV RNA level resulted in an IRR of 1.77 (95% CI: 0.98, 3.21). No prior antiretroviral therapy use (P-value <0.001), higher HIV RNA level (P-value = 0.01), lower CD4 count (P-value = 0.01), younger age (P-value = 0.01), and alcohol use (P-value = 0.04) were independent predictors of pneumonia. HAART use decreased pneumonia risk (IRR 0.28, 95% CI: 0.18, 0.44). Conclusions: While HIV-positive smokers had over a 2-fold increase in the rate of pneumonia, the trend did not reach statistical significance in multivariable models. Clinical factors such as HAART, alcohol use and immunological status are important in pneumonia risk.